MEDICAL ADVISORS
A graduate in Biochemistry and Medicine from the University of Birmingham, and a Fellow and the 2018 President of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. Alan was previously Chair of the Specialist Advisory Committee in Pharmaceutical Medicine at The Royal College of Physicians.
In November 2009 he was appointed an Honorary Professor at the College of Medical and Dental Sciences at the University of Birmingham Medical School, in recognition of his expertise in medicines development. In October 2014, he was elected as a fellow of the Royal Society of Biology.
Alan sits on Micregen’s advisory board and is Micregens’ Pre Clinical - Chief Medical Officer for its first target indications.
Prof. Kate Costeloe CBE, BChir MB, Advisory Board Chair, Retired as a neonatologist, Professor of Paediatrics at Queen Mary University of London, Professor of Paediatrics at Barts and the London Hospitals and Honorary Consultant at Homerton University Hospital, London.
Kate led a number of important research projects in the field of neonatology, including outcomes following extremely preterm birth and the prevention of necrotising enterocolitis. She is Co-Chair of the Steering Board of the Neonatal Data Analysis Unit at Imperial College London.
In 2016 Kate was awarded the James Spence Medal for outstanding contributions to the advancement or clarification of paediatric knowledge, it is the highest honour bestowed by The Royal College of Paediatrics and Child Health.
Kate is the chair of Micregen's Child indication Advisory Board.
Qualified Person, Quality Systems Management & cGMP Auditor, QP Assessor for the Royal Pharmaceutical Society of Great Britain and holds the office of Vice-Chair of the Royal Pharmaceutical Society panel of QP Assessors and was recently appointed as a Fellow of the Royal Pharmaceutical Society.
Experienced in the life sciences industry since 1984 holding roles including Global Head of Quality for Genzyme’s Clinical Supplies Department and past chair of Investigational Product COP (IP COP) Council.
Robert was the co-author of the Supply Chain Management Chapter of the ISPE Good Practice Guide for the Development of Investigational Biological Products and played a major role the production of the ISPE Good Practice Guide on Interactive Response Technology.
Dr. Zani is a medically qualified doctor who completed his paediatric surgical training at Sapienza University of Rome, Italy in 2006. He is also a doctor in research having gained his PhD from University College London, U.K., in 2013, where his investigations focused on the development of novel stem cell therapies for necrotizing enterocolitis.
It was during his time at UCL that Augusto made one of the landmark discoveries showing the potential of amniotic fluid stem cells as a therapy for necrotizing enterocolitis. Thereafter, he left the UK to take up a fellowship in neonatal surgery at the Hospital for Sick Children (SickKids), Toronto, Canada in 2014. Augusto’s achievements were recognised in 2016 when he was appointed as a Staff Surgeon in the Division of General and Thoracic Surgery at SickKids.
Augusto has made several major discoveries that advance our understanding of the causes of conditions including pulmonary hypoplasia and is working with Micregen to identify new therapeutic avenues as treatments.
Chair of the British Society for Research on Ageing, Fellow of the Higher Education Academy, Professor of Stem Cell Biology, Ageing and Molecular Physiology Unit Research Institute for Sport & Exercise Sciences, John Moores University. Claire is Chairperson of Micregen’s Healthy Ageing Advisory Board.
